Congratulations Mehreen Datoo
TIME has today named Associate Fellow Dr Mehreen Datoo to the 2024 TIME100 Next list.
An expansion of the TIME100 list of the most influential people in the world, TIME100 Next highlights 100 emerging leaders who are shaping the future of business, entertainment, sports, politics, health, science and activism, and more.
The full list and related tributes appear in the October 14, 2024 issue, available on newsstands on Friday 4 October, and now at time.com/next. Professor Adrian Hill writes of Mehreen,
‘In her 20s, Dr Mehreen Datoo contracted malaria while conducting research in Uganda. She was hospitalised before recovering. In the years since, her work has been central to the clinical development of the new malaria vaccine, R21/Matrix-M, from early-phase clinical trials to regulatory approval. This year the vaccine was deployed. It’s now being administered to children in sub-Saharan Africa and will be game – changing in the fight against malaria, which in 2022 killed 608,000 people, three-quarters of them children under age 5.
‘A clinical lecturer and specialty trainee doctor in infectious diseases and microbiology at Oxford University, Mehreen has worked tirelessly over the past seven years with experts across multiple continents to achieve this goal. Her team’s efforts will help reduce the incidence of malaria globally, as well as have a direct impact on the health and quality of life of children and their families and communities.’
Adrian Hill is director of the Jenner Institute at Oxford University and led work on R21/Matrix-M.
Dr Mehreen Datoo is an Associate Fellow of Green Templeton College and a Clinical Lecturer in Infectious Diseases, Nuffield Department of Medicine, University of Oxford.
Mehreen is an experienced Clinical Research Fellow with a demonstrated history of working in pioneering vaccine research at the Jenner Institute, University of Oxford. She has been central to the Oxford R21/Matrix-M™ malaria vaccine team that received WHO recommendation for use in 2023, paving the way for global roll-out.
Now in its fifth year, the TIME100 Next list was created to recognise that many of today’s most influential leaders are individuals who are not waiting long in life to make an impact. Nor are they eager to respect the status quo by following the traditional power structures and pathways that have determined what influence looked like in the past. TIME100 Next has no age requirements; its aim is to recognise that influence does not have them either, nor does leadership look like it once did.
Mehreen will join other 2024 honourees in New York City later in October.
